Manufacturing Issues Block Astellas From a First-in-Class Cancer Drug Approval
Astellas Pharma’s path to winning the first drug approval for a particular promising gastrointestinal cancer target has hit a detour. ...
Astellas Pharma’s path to winning the first drug approval for a particular promising gastrointestinal cancer target has hit a detour. ...
Loewen Cavill, co-founder and CEO of Amira, never expected to work in the menopause space. But then her aunt was ...
The legal status of marijuana in the United States is comparable to the Korean War: The conflict ceased long ago, ...
Medical device giant Boston Scientific announced a $3.7 billion deal on Monday to augment its urology portfolio. The company is ...
When the Covid-19 pandemic hit, contract development and manufacturing organizations (CDMOs) became indispensable partners to the biopharmaceutical companies that developed ...
Imagine being a parent to a 20-month-old and learning through a developmental screening that your toddler might have autism spectrum ...
Goldman Sachs Asset Management has expanded to biotech investments in recent years. The investment firm is now preparing to ramp ...
Clinical trial attrition can be detrimental to clinical outcomes, patient well-being and the financial health of research programs. Clinical trial ...
The Israeli cybersecurity industry, much like the global one, has been undergoing an evolution that seemed to peak in 2021 ...
As a startup, it’s like a rite of passage to look for funding in order to grow your business. But ...
Copyright © 2024 DerInformant.
DerInformant.com is not responsible for the content of external sites.
DerInformant.com is a proud member of BXL MEDIA
Copyright © 2024 DerInformant.
DerInformant.com is not responsible for the content of external sites.
DerInformant.com is a proud member of BXL MEDIA
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.